Daiwa Securities Group Inc. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$10.0%1910.0%0.00%
Q1 2024$10.0%1910.0%0.00%
Q4 2023$10.0%1910.0%0.00%
Q3 2023$10.0%1910.0%0.00%
Q2 2023$10.0%1910.0%0.00%
Q1 2023$10.0%1910.0%0.00%
Q4 2022$1
-100.0%
1910.0%0.00%
Q3 2022$2,0000.0%1910.0%0.00%
Q2 2022$2,0000.0%1910.0%0.00%
Q1 2022$2,000
-33.3%
1910.0%0.00%
Q4 2021$3,0000.0%1910.0%0.00%
Q3 2021$3,0000.0%191
+59.2%
0.00%
Q2 2021$3,000
+50.0%
1200.0%0.00%
Q1 2021$2,0000.0%1200.0%0.00%
Q4 2020$2,000
-33.3%
120
-60.1%
0.00%
Q3 2020$3,0000.0%3010.0%0.00%
Q2 2020$3,0000.0%3010.0%0.00%
Q1 2020$3,000
-40.0%
3010.0%0.00%
Q4 2019$5,000
+25.0%
301
-10.1%
0.00%
Q3 2019$4,000
-20.0%
3350.0%0.00%
Q2 2019$5,000
-16.7%
3350.0%0.00%
Q1 2019$6,0000.0%335
+35.1%
0.00%
Q4 2018$6,0000.0%2480.0%0.00%
Q3 2018$6,000
+20.0%
2480.0%0.00%
Q2 2018$5,000
+25.0%
2480.0%0.00%
Q1 2018$4,0002480.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders